# FDA Inspection 782613 - Ulmer Pharmacal Co - May 17, 2012

Source: https://www.keypedia.com/records/fda_inspections/ulmer-pharmacal-co/0e7ea3ec-fedd-48d6-b2c0-a6cb7cd80b83
Source feed: FDA_Inspections

> FDA Inspection 782613 for Ulmer Pharmacal Co on May 17, 2012. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 782613
- Company Name: Ulmer Pharmacal Co
- Inspection Date: 2012-05-17
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1177172 - 2022-08-01](https://www.keypedia.com/records/fda_inspections/ulmer-pharmacal-co/1d7564ec-ffae-4bcb-a3c2-5f7d32fcade8)
- [FDA Inspection 1021833 - 2017-08-02](https://www.keypedia.com/records/fda_inspections/ulmer-pharmacal-co/d31ef4f8-2566-4af0-b262-027868d31e4c)
- [FDA Inspection 791562 - 2012-07-11](https://www.keypedia.com/records/fda_inspections/ulmer-pharmacal-co/4764df64-74e1-469c-8cc7-814b3be196dd)
- [FDA Inspection 608267 - 2009-08-19](https://www.keypedia.com/records/fda_inspections/ulmer-pharmacal-co/adae4ce7-11b7-457c-b30b-0e490cc61175)

Company: https://www.keypedia.com/companies/ulmer-pharmacal-co/9bb0856f-4b95-4d72-bd9b-c5fe3f661099

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c